VRCA compared with SNDL: revenue, margins and what each company keeps, and the suppliers and customers both name

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

SNDLSndl Inc.

Mkt capRevenueRevenue

Compare

VRCAVerrica Pharmaceuticals Inc.

SNDLSndl Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

VRCAVerrica Pharmaceuticals Inc.

3.20▼−4.48%· post 3.27

Mkt cap$57.5MRevenue$6MQ2 FY26Revenue$36MFY25

SNDLSndl Inc.

1.28▲+3.00%· post 1.28

ClosedNov 2 '26

Mkt cap$326.6MRevenue—Revenue—

Compare

ClosedNov 2 '26

VRCAVerrica Pharmaceuticals Inc.

SNDLSndl Inc.

3.20▼−4.48%post 3.27

Price

1.28▲+3.00%post 1.28

$57.5M

Mkt cap

$326.6M

Q2 FY26$6M

Revenue

—

FY25$36M

Revenue

—

VRCA3.20▼−4.48%vsSNDL1.28▲+3.00%ClosedNov 2 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

VRCA: latest quarter is a loss; flow not drawable. SNDL: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VRCA 1

—Lytix BioPharma ASunlistedsupplier

Shared 0

No shared counterparties.

Only SNDL 1

—Alberta Gaming, Liquor and Cannabisunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

VRCA, solidSNDL, dashed